Patent details

EP3823664 Title: BISPECIFIC ANTI-BCMA X ANTI-CD3 ANTIBODIES AND USES THEREOF

Basic Information

Publication number:
EP3823664
PCT Application Number:
US2019042447
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP197490964
PCT Publication Number:
WO2020018820
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BISPECIFIC ANTI-BCMA X ANTI-CD3 ANTIBODIES AND USES THEREOF
French Title of Invention:
ANTICORPS ANTI-BCMA X ANTI-CD3 BISPÉCIFIQUES ET LEURS UTILISATIONS
German Title of Invention:
BISPEZIFISCHE ANTI-BCMA-X-ANTI-CD3-ANTIKÖRPER UND IHRE VERWENDUNGEN
SPC Number:

Dates

Filing date:
18/07/2019
Grant date:
08/01/2025
EP Publication Date:
26/05/2021
PCT Publication Date:
23/01/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/01/2025
EP B1 Publication Date:
08/01/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/07/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/01/2025
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Agent

Name:
NLO
From:
17/01/2025
Address:
P.O. Box 29720, 2502 LS The Hague, Netherlands (NL)
To:

Inventor

1

Name:
ZHANG, Qian
Address:
United States (US)

2

Name:
SINESHCHEKOVA, Olga
Address:
United States (US)

3

Name:
DILILLO, David
Address:
United States (US)

4

Name:
OLSON, Kara
Address:
United States (US)

5

Name:
SMITH, Eric
Address:
United States (US)

6

Name:
DELFINO, Frank
Address:
United States (US)

7

Name:
KIRSHNER, Jessica
Address:
United States (US)

Priority

1

Priority Number:
201862700596 P
Priority Date:
19/07/2018
Priority Country:
United States (US)

2

Priority Number:
201862750968 P
Priority Date:
26/10/2018
Priority Country:
United States (US)

3

Priority Number:
201962793645 P
Priority Date:
17/01/2019
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; A61P 35/02; C07K 16/28;

Publication

European Patent Bulletin

Issue number:
202502
Publication date:
08/01/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/07/2025
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
17/01/2025 Power Of Attorney 1
17/01/2025 Outgoing Correspondence 1
22/01/2025 Power Of Attorney 1